EUVIMEDEUVIMED entdecken
Crossref

Alcohol Biomarker Phosphatidylethanol as a Predictor of the Severity of Alcohol Withdrawal Syndrome

Lan Novak, Leila M Soravia, Adina Bünter, Frederike Stöth, Alexander Wopfner, Wolfgang Weinmann, Philippe Pfeifer

Alcohol and Alcoholism · 2023

DOI: 10.1093/alcalc/agac071 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Alcohol and Alcoholism, 2023. Verfasst von Lan Novak und 6 weiteren Autor:innen. Beteiligte Einrichtung: Suedhang Clinic, Center for Treatment of Addictive Disorders, Kirchlindach 3038, Switzerland. Hauptthemen laut MEDLINE: Alcoholism, Substance Withdrawal Syndrome. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 28 Literaturangaben. Gefördert von: Swiss Foundation for Alcohol Research.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims to investigate the relationship between phosphatidylethanol (PEth) and withdrawal severity in patients with alcohol use disorder (AUD). Methods in 34 patients with AUD admitted for treatment of acute alcohol withdrawal, data were available for initial blood PEth concentrations and scores throughout detoxification of symptoms of withdrawal assessed by trained medical staff using the alcohol withdrawal syndrome (AWS)-scale, a validated scale consisting of 11 items in the alcohol withdrawal syndrome (two subscales with seven physiological and five psychological symptoms). Results a significant positive correlation between PEth and the severity of alcohol withdrawal was found. When the sample was divided into two groups, according to whether or not AWS score at some point in the treatment reached 6 or more, the median PEth score was higher in those whose peak score had been 6 or more (score of 6 being the suggested cutoff to start medicating the withdrawal syndrome). Although there was a trend for some aspects of the clinical history to be more ‘severe’ in those with higher AWS, no differences reached significance. Conclusion blood PEth on admission could have a role in identifying patients at risk of more severe AWS.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AlcoholismSubstance Withdrawal SyndromeHumansEthanolGlycerophospholipidsAlcohol DrinkingBiomarkers

Stichwörter der Autor:innen

alcohol biomarkeralcohol use disorderphosphatidylethanolwithdrawal

Substanzen

phosphatidylethanolEthanolGlycerophospholipidsBiomarkers

Autor:innen und Institutionen

  • Suedhang Clinic, Center for Treatment of Addictive Disorders, Kirchlindach 3038, Switzerland.
  • University Hospital of Psychiatry and Psychotherapy, University of Bern, Bern 3012, Switzerland.
  • Institute of Forensic Medicine, University of Bern, Bern 3012, Switzerland.

Förderung

  • Swiss Foundation for Alcohol Research

Zitieren

APA

Novak, L., Soravia, L. M., Bünter, A., Stöth, F., Wopfner, A., Weinmann, W., & Pfeifer, P. (2023). Alcohol Biomarker Phosphatidylethanol as a Predictor of the Severity of Alcohol Withdrawal Syndrome. Alcohol and Alcoholism. https://doi.org/10.1093/alcalc/agac071

Vancouver

Novak L, Soravia LM, Bünter A, Stöth F, Wopfner A, Weinmann W, et al. Alcohol Biomarker Phosphatidylethanol as a Predictor of the Severity of Alcohol Withdrawal Syndrome. Alcohol and Alcoholism. 2023. doi:10.1093/alcalc/agac071

BibTeX
@article{Novak2023,
  author = {Novak, Lan and Soravia, Leila M and Bünter, Adina and Stöth, Frederike and Wopfner, Alexander and Weinmann, Wolfgang and Pfeifer, Philippe},
  title = {Alcohol Biomarker Phosphatidylethanol as a Predictor of the Severity of Alcohol Withdrawal Syndrome},
  journal = {Alcohol and Alcoholism},
  year = {2023},
  doi = {10.1093/alcalc/agac071}
}
Kostenlos starten →